Understanding Immunity to the COVID-19 Vaccines

Completed

• Conditions: Immunity; COVID-19; Vaccine
• Interventions: Other: No intervention

• Registration Number: NCT04664309
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-12-09
• Study First Submitted QC: 2020-12-09
• Study First Posted: 2020-12-11
• Study Start: 2021-03-26
• Primary Completion: 2022-01-06
• Study Completion: 2022-01-06
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-09
• Last Update Posted: 2022-02-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Adults who are receiving a COVID-19 vaccine

Exclusion Criteria

• Patients with special risks attendant to venipuncture

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Participants	No intervention	Adults who are receiving a COVID-19 vaccine

Primary Outcome Measures

Name	Time	Method
Percentage of participants with immunity to COVID-19 vaccines over time	1 year

Trial Locations

Locations (1)

Stanford University, Hospital, and Clinics; 🇺🇸 Stanford, California, United States